Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2001 1
2002 18
2003 10
2004 18
2005 13
2006 20
2007 20
2008 30
2009 20
2010 32
2011 30
2012 29
2013 26
2014 27
2015 29
2016 21
2017 17
2018 33
2019 28
2020 31
2021 25
2022 23
2023 35
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

464 results

Results by year

Filters applied: . Clear all
Page 1
The History of the EBIR.
Uberoi R, Nice C, Morgan R. Uberoi R, et al. Among authors: morgan r. Cardiovasc Intervent Radiol. 2023 Jan;46(1):1-4. doi: 10.1007/s00270-022-03310-z. Epub 2022 Nov 7. Cardiovasc Intervent Radiol. 2023. PMID: 36344801 No abstract available.
Cervical cancer.
Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR 3rd, Morgan M, Morgan RJ Jr, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small W Jr, Teng N; National Comprehensive Cancer Network. Greer BE, et al. Among authors: morgan rj jr. J Natl Compr Canc Netw. 2008 Jan;6(1):14-36. doi: 10.6004/jnccn.2008.0003. J Natl Compr Canc Netw. 2008. PMID: 18267056 No abstract available.
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Carter BZ, Mak PY, Muftuoglu M, Tao W, Ke B, Pei J, Bedoy AD, Ostermann LB, Nishida Y, Isgandarova S, Sobieski M, Nguyen N, Powell RT, Martinez-Moczygemba M, Stephan C, Basyal M, Pemmaraju N, Boettcher S, Ebert BL, Shpall EJ, Wallner B, Morgan RA, Karras GI, Moll UM, Andreeff M. Carter BZ, et al. Among authors: morgan ra. Blood. 2023 Sep 21;142(12):1056-1070. doi: 10.1182/blood.2022019047. Blood. 2023. PMID: 37339579
Dialysis Access Maintenance: Plain Balloon Angioplasty.
Ratnam L, Karunanithy N, Mailli L, Diamantopoulos A, Morgan RA. Ratnam L, et al. Among authors: morgan ra. Cardiovasc Intervent Radiol. 2023 Sep;46(9):1136-1143. doi: 10.1007/s00270-023-03441-x. Epub 2023 May 8. Cardiovasc Intervent Radiol. 2023. PMID: 37156943 Free PMC article. Review.
IR voices about COVID 19.
Morgan R, Arabi M, Arai Y, Das M, Golzarian J, Holden A, Roy-Choudhury SH, Spiliopoulos S, Teng GJ, Tsitskari M. Morgan R, et al. CVIR Endovasc. 2020 Jul 7;3(1):45. doi: 10.1186/s42155-020-00136-z. CVIR Endovasc. 2020. PMID: 32638186 Free PMC article. No abstract available.
Surgical Management of Vulvar Cancer.
Dellinger TH, Hakim AA, Lee SJ, Wakabayashi MT, Morgan RJ, Han ES. Dellinger TH, et al. Among authors: morgan rj. J Natl Compr Canc Netw. 2017 Jan;15(1):121-128. doi: 10.6004/jnccn.2017.0009. J Natl Compr Canc Netw. 2017. PMID: 28040722 Review.
Cervical cancer.
Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR 3rd, Martin L, Morgan MA, Morgan RJ Jr, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Valea FA; National Comprehensive Cancer Networks. Greer BE, et al. Among authors: morgan rj jr. J Natl Compr Canc Netw. 2010 Dec;8(12):1388-416. doi: 10.6004/jnccn.2010.0104. J Natl Compr Canc Netw. 2010. PMID: 21147903 No abstract available.
Secondary Endoleak Management Following TEVAR and EVAR.
Ameli-Renani S, Pavlidis V, Morgan RA. Ameli-Renani S, et al. Among authors: morgan ra. Cardiovasc Intervent Radiol. 2020 Dec;43(12):1839-1854. doi: 10.1007/s00270-020-02572-9. Epub 2020 Aug 10. Cardiovasc Intervent Radiol. 2020. PMID: 32778905 Free PMC article. Review.
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.
Morgan RD, Clamp AR, White DJ, Price M, Burghel GJ, Ryder WDJ, Mahmood RD, Murphy AD, Hasan J, Mitchell CL, Salih Z, Wheeler C, Buckley E, Truelove J, King G, Ainaoui Y, Bhaskar SS, Shaw J, Evans DGR, Kilerci B, Pearce SP, Brady G, Dive C, O'Connor JPB, Wallace AJ, Rothwell DG, Edmondson RJ, Jayson GC. Morgan RD, et al. Clin Cancer Res. 2023 Jul 14;29(14):2602-2611. doi: 10.1158/1078-0432.CCR-22-3282. Clin Cancer Res. 2023. PMID: 36799931
464 results